EchoNext: detecting structural heart disease from ECGs with AI
EchoNext was trained on more than one million heart-rhythm and imaging records to detect structural heart disease. The journal abstract reports internal and external validation, a controlled comparison outperforming cardiologists, and prospective clinical-trial evaluation in patients without previous cardiac imaging that identified undiagnosed disease. This supports a screening study, not proof that deployment improves patient outcomes. The authors also released model weights and an annotated dataset.
Technology: EchoNext (deep learning model on 12-lead ECG)
Publication: Peer-reviewed paper · Test context: prospective or independent check. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: prospective or independent check
- Tested: Internal/external diagnostic validation, a controlled cardiologist comparison and prospective clinical-trial screening of patients without previous cardiac imaging.
- Still unknown: Abstract and publication metadata reviewed. No claim of mortality reduction, universal clinical generalization or independent replication is made.
- AI role: A deep-learning model estimated structural-heart-disease risk from electrocardiograms to guide imaging-based screening.
Evidence sources: https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=DOI%3A%2210.1038%2Fs41586-025-09227-0%22&resultType=core&format=json
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review scope and date are not recorded; source checked does not establish full-text review.
Citations: in the top 1% of works of the same type, year and subfield (OpenAlex work metrics, 163 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.
Editorial assessment: Impact 5/5 · Validation 4/5 · Novelty 4/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.